Are generic drug prices going up or down? Depends on which benchmark you ask
Same drug, thousands of prices: Crossing Medicare’s Catastrophic Coverage finish line
Ben LinkMedicare, PBM, Part D, Copaxone, Inflation Reduction Act, Catastrophic Coverage, IRA, NADAC, Mark Cuban, MFP, Januvia, Novolog, Farxiga, Enbrel, Jardiance, Stelara, Xarelto, Eliquis, Entresto, Imbruvica, WAC, Express Scripts, CVS, Optum, Kaiser, 340B
Medicare’s addiction to disconnected drug prices
Ben LinkGeneric, Medicare, PBM, Part D, AWP, dispensing fee, Transparency in Coverage, Suboxone, Buprenorphine-naloxone, opioid use disorder, addiction treatment, NADAC, Medicaid
Is 2024 the start of a brave new world in drug pricing?
Ben LinkWAC, AWP, PBM, Brand drugs, Generic drugs, NADAC, CVS, Express Scripts, Medicaid, Mark Cuban, Insulin, Flovent, Price increases, List prices, Rebates, American Rescue Plan, Inflation Reduction Act, AMP
How PBMs distort and undermine specialty drug pricing guarantees
Ben LinkSpecialty, WAC, AWP, specialty drugs, PBM, Brand drugs, Generic drugs, Effective rate, NADAC, Linda Cahn, CVS, Express Scripts, Optum, Emgality, Retevmo, Imatinib, Gleevec, Hyalgan, Medicaid, Medicare, Mark Cuban, Ohio
Medicare hits $200 billion in gross drug spend: Who gets the blame?
Ben LinkMedicare, Part D, Brand drugs, Generic drugs, Specialty, DIR fees, Rebates, PBM, Eliquis, Revlimid, Xarelto, Januvia, Trulicity, Imbruvica, Lantus, Jardiance, Humira, Ibrance, NADAC, atorvastatin, WAC
Wreck-fidera: How Medicare Part D has hidden the benefits of generic competition for a blockbuster Multiple Sclerosis treatment
Ben LinkMedicare, Copaxone, Teva, Rebates, Tecfidera, Biogen, Multiple Sclerosis, WAC, Mylan, NADAC, specialty drugs, Kaiser, CVS, UnitedHealthcare, Cigna, Anthem, Humana, Centene, DIR fees, AWP, Plan Finder
International reference pricing: Discounts Down Under far surpass U.S. drug price concessions
Ben LinkAustralia, International pricing, PBM, NADAC, Eliquis, Rebates, Advair, Fluticasone, Gleevec, Imatinib, Part D, Part B, Aetna, Albuterol
Two new dashboards released to assist with drug shortage research
Ben LinkCOVID-19, China, India, FDA, Drug shortages, drug prices, NADAC, Omeprazole, Medicaid, Prilosec, Lisinopril, Epclusa, sofosbuvir, naproxen, hydrocodone, ranitidine, hydroxychloroquine
